What does MRD stand for?

Matched Related Donor

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Marine Design Center Marine Resources Division (various states) Market Rate of Demand Market Regulation Division (stock exchanges; various locations) Market Release Date Market Requirements Document Marketing Requirements Document Marketing Research Department Master Requirements Directory Master Requirements Document		Material Receipt Date Material Release Document Material Required Date Material Requirements Data Materiel Redistribution Division Materiel Release Denial Materiel Requirements Document Maximum Rank Distance Maximum Relative Density (asphalt) Maximum Release Date

Samples in periodicals archive:

2 The ability to suppress organ rejection with cyclosporin effectively provided a new supply of input resources (kidneys) into the system, a supply heretofore constrained by the need for, but the scarcity of, closely matched related donors.

Transplantation

Christian Fibich, Alberta Bone-Marrow Transplant Program, University of Calgary, Canada Tuesday, 12/10/02, 8:45am, Room 202, Oral Matched Related Donor (MRD) BMT Abstract #1663 - Improved Survival in Adult Matched Sibling Stem Cell Transplant (SCT) Recipients Given Pretransplant Low-Dose Antithymocyte Globulin (ATG): A Matched Pair Analysis.

New Thymoglobulin Data in More Than 30 Presentations Expected at the ...

Forman, MD, co-investigator Monday, December 9, 2002, 7:30 AM, Simultaneous Session: Allogeneic Matched Related Donor Transplantation for Leukemia (7:30 AM-9:15 AM) Ballroom A Study suggests that the use of peripheral blood stem cells might, over time, improve the effectiveness and cure rate of patients undergoing transplant for CML.

City of Hope Cancer Center Announces Research to Be Presented at 44th ...

Unrelated donor recipients are at significantly greater risk of treatment-related complications including infections and cancer relapse than patients receiving transplants from matched related donors.

CELL THERAPEUTICS INITIATES PHASE III TRIAL OF LISOFYLLINE IN ...